Weight Watchers launches an integrated platform combining GLP-1 prescriptions, personalized nutrition, and behavioral support for effective weight management.
Quiver AI Summary
WW International, Inc. (Weight Watchers) announced a new integrated weight management experience that combines GLP-1 medication prescribing, personalized nutrition, behavioral support, and community features through a revamped app and digital platform. This new offering is designed to help members achieve lasting results by providing coordinated, science-backed support tailored to individual needs. The Weight Watchers Med+ program gives members access to board-certified physicians for GLP-1 prescriptions and a structured GLP-1 Success program that includes nutrition guidance and community support. The redesigned digital experience features a Weight Health Score, AI body scanning, and tailored fitness content, all aimed at improving members' understanding of their progress. Weight Watchers emphasizes community-driven support and an updated brand identity that reflects its commitment to personalized health management. The new experience will begin rolling out on December 26, 2025.
Potential Positives
- Weight Watchers has launched a new integrated experience that combines GLP-1 prescribing, personalized nutrition, and behavioral support, enhancing its service offering to members.
- The introduction of the Weight Health Score and AI-powered body scanner provides members with valuable insights and a clearer understanding of their progress, especially those using GLP-1 medications.
- The company reports that more than 70% of Weight Watchers Med+ members on the GLP-1 Success Program find it effective in minimizing medication side effects, thereby increasing user satisfaction.
- Weight Watchers is evolving its brand identity to reflect its comprehensive and personalized approach to weight management, appealing to a wider audience in the health landscape.
Potential Negatives
- The introduction of the GLP-1 prescribing aspect may raise concerns about the ethical implications of a weight management company also acting as a provider of prescription medications, potentially leading to scrutiny from regulatory bodies.
- The reliance on GLP-1 medications, which may not be suitable for all individuals, suggests a possible limitation in the program's inclusivity, potentially alienating portion of prospective members who cannot or choose not to use these medications.
- The extensive focus on GLP-1 medications might overshadow other essential components of weight management, leading to a perception that the company is overly dependent on medication rather than a holistic approach to health and wellness.
FAQ
What is the new Weight Watchers experience?
Weight Watchers introduced a fully integrated system combining GLP-1 prescribing, personalized nutrition, coaching, and community support within a redesigned app.
How does Weight Watchers Med+ support members?
Weight Watchers Med+ offers GLP-1 medications through board-certified physicians and provides a dedicated care team for ongoing medical guidance.
What is the GLP-1 Success Program?
The GLP-1 Success Program provides personalized nutrition, tools to track progress, support for side effects, and community connection for those using GLP-1 medications.
How does the new digital experience improve member outcomes?
The digital experience features a Weight Health Score and AI body scanner to help members track progress and improve their metabolic health.
When will the new Weight Watchers app be available?
The new Weight Watchers app experience will begin rolling out globally starting on December 26, 2025.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$WW Insider Trading Activity
$WW insiders have traded $WW stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $WW stock by insiders over the last 6 months:
- CARNEY HAWKS has made 2 purchases buying 29,057 shares for an estimated $643,464 and 0 sales.
- NICOLE HAAG (Corp Controller Prin Acct Off) sold 469 shares for an estimated $14,474
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$WW Revenue
$WW had revenues of $172.1M in Q3 2025. This is a decrease of -10.78% from the same period in the prior year.
You can track WW financials on Quiver Quantitative's WW stock page.
$WW Hedge Fund Activity
We have seen 80 institutional investors add shares of $WW stock to their portfolio, and 13 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARISTEIA CAPITAL, L.L.C. added 900,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $24,624,000
- CARRONADE CAPITAL MANAGEMENT, LP added 446,615 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,219,386
- JPMORGAN CHASE & CO added 381,231 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,430,480
- CONTRARIUS GROUP HOLDINGS LTD added 376,431 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,299,152
- BALYASNY ASSET MANAGEMENT L.P. added 297,525 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,140,284
- AEGON USA INVESTMENT MANAGEMENT, LLC added 293,854 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,039,845
- MILLENNIUM MANAGEMENT LLC added 282,435 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,727,421
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$WW Analyst Ratings
Wall Street analysts have issued reports on $WW in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- LUCID CAPITAL MARKETS issued a "Buy" rating on 07/08/2025
To track analyst ratings and price targets for $WW, check out Quiver Quantitative's $WW forecast page.
$WW Price Targets
Multiple analysts have issued price targets for $WW recently. We have seen 2 analysts offer price targets for $WW in the last 6 months, with a median target of $50.5.
Here are some recent targets:
- Lauren Schenk from Morgan Stanley set a target price of $41.0 on 08/12/2025
- Alex Fuhrman from LUCID CAPITAL MARKETS set a target price of $60.0 on 07/08/2025
Full Release
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience that unites GLP-1 prescribing, personalized nutrition, behavioral support, coaching, and community within a redesigned app experience and digital platform. Built for a new era of weight management and long-term health, the new integrated offering delivers coordinated, evidence-based support that adapts to members’ lives and helps them achieve—and sustain—superior results.
"People want safe, expert access to GLP-1 medications, support that fits the way they actually live, and most importantly, real and sustainable results. This is what Weight Watchers delivers. In fact, members who use GLP-1s while engaging with the Weight Watchers program lose more weight and report higher satisfaction and quality of life—which is why 90% of surveyed GLP-1 users expressed interest in joining community-based support programs like ours," said Tara Comonte, CEO of Weight Watchers . "Weight Watchers combines access to specialist physicians who prescribe GLP-1s to eligible members, six decades of effective behavior change backed by science, and a community that knows what it takes to succeed. Now, we are building on this foundation with a redesigned user experience and new tools that are easy to use, easy to follow, and tailored to each members’ unique needs to help them reach their goals and achieve results that last."
Weight Watchers Med+ and New GLP-1 Success Program
Weight Watchers Med+ is the company’s dedicated GLP-1 medical program
, providing members access to board-certified physicians and a coordinated care team who specialize in obesity and metabolic health. These clinicians write prescriptions for GLP-1 medications for eligible members and offer ongoing medical guidance throughout treatment. What truly sets Med+ apart is that every member prescribed GLP-1s also receives the full GLP-1 Success experience—a structured behavioral, nutritional, and lifestyle support program that research shows achieves better results on medication.
This newly launched GLP-1 Success program is built around the real needs of people using these medications. Members receive personalized nutrition guidance to help them meet important macronutrient goals, tools to track weight loss and medication doses, strategies and support for managing side effects, and strength-building plans to help preserve muscle mass. The program also provides access to expert coaches trained in GLP-1 support, and virtual community groups with others on a similar journey. By pairing medical care with the GLP-1 Success framework, Med+ delivers a complete solution that goes far beyond prescription-only services—and drives stronger outcomes for members than medication alone. In addition, more than 70% of Weight Watchers Med+ members on the GLP-1 Success Program say that it helps them minimize weight loss medication side effects.
For those who receive their GLP-1 prescriptions from an alternative medical provider, Weight Watchers is also offering the GLP-1 Success Program as a standalone option . These members receive the same comprehensive lifestyle, nutrition, movement, coaching, and community support as those on Med+, ensuring that anyone taking GLP-1s can access the structure and guidance needed to use these medications safely, effectively and successfully.
A New Digital Experience Designed to Power Better Results
In addition to its GLP-1 Success and Med+ solutions, Weight Watchers is unveiling a reimagined digital experience that combines decades of behavior-change expertise with new technology to give members a clearer, more personalized view of their weight health and help them be more successful in reaching and sustaining their goals.
-
Weight Health Score, a simple, science-based view of progress
At the center of the new experience is the new Weight Health Score, an evidence-based metric that turns daily habits into an easy to understand scoring system. It draws on key inputs such as body composition–as well as nutrition, activity, and sleep–from more than 60 connected devices and apps, giving members a clearer sense of which habits are driving their overall progress.
-
AI Body Scanner, making changes easier to detect
A new AI-powered body scan tracks changes in fat and muscle mass over time, offering insights that a scale alone cannot provide. This is especially important for members using GLP-1 medication who may see substantial changes in body weight, and benefit from a clearer picture that supports fat loss while preserving muscle mass and strength.
-
Exclusive Fitness Content
Members will gain access to premium fitness content directly within the app, including progressive strength and functional movement programming from The LIFTED Method by Holly Rilinger. This program supports members at every stage of their journey—whether they’re navigating menopause, using GLP-1 weight-loss medications, or simply looking to build sustainable movement into a healthier lifestyle.
-
Modes That Adjust To Changing Needs
As members move through different phases in their weight journey, they can now select between flexible Modes which adjust the level and type of support. Initial modes include All-In Mode, a more structured pathway for those looking to jump-start their progress; Lose Mode, Weight Watchers’ trusted approach that provides members with a consistent foundation for steady, sustainable progress; and Maintain Mode, focused on preserving results over time.
“GLP-1 medications are powerful tools that deliver even better results when combined with behavioral support, good nutrition, movement, and ongoing monitoring. That’s why members who use Weight Watchers programming to guide their GLP-1 journey are better equipped to achieve their goals and protect their results, said Dr. Kim Boyd, Chief Medical Officer of Weight Watchers. “By integrating medical care with tools like the Weight Health Score and our AI body scanner, we can help members understand their progress more accurately to improve their metabolic health and sustain results long-term.”
Enhanced Community-First Support
What sets Weight Watchers apart is the power of real human connection. Building on a 62-year legacy of community support, Weight Watchers’ deeply experienced coaches—along with a growing group of physicians who will also lead select groups—help members navigate the real-life challenges of sustainable weight management. This offering is being expanded with a richer virtual experience and growing line up of curated programming to bring this support to more people, wherever they are.
Members can join small, coach-led groups—including those focused on GLP-1 use, menopause, nutrition, or movement— to learn from others on a similar path and feel truly supported. Whether managing GLP-1 side effects, staying consistent during busy seasons or holidays, rebuilding routines after a setback, or celebrating progress in all its forms, these communities provide support and proven success for members above and beyond results when going it alone.
A Bold Refreshed Brand For A New Era Of Weight Health
Inspired by feedback from its members, Weight Watchers is introducing an updated brand identity that reflects the company’s evolution across its platform and within the broader health landscape. The new identity represents who Weight Watchers is today—integrated, intelligent, evidence-based, and always grounded in real-life human care.
The bold new logo conveys stability, trust, and the brand’s reputation for sustainable health outcomes. The progress bar, drawn from members’ journeys, underscores that weight loss is deeply personal and emotional. Modern typography brings the system together, creating a unified and inspiring brand experience that celebrates progress and personalization.
“This evolution goes far beyond a new visual identity. For us, the Weight Watchers brand lives in how we show up every day—through our experience, our coaches, our community, and our medical support,” said Julie Rice, Chief Experience Officer at Weight Watchers . “Everything is designed around a deep understanding of members’ real lives and goals, so support feels personal, connected, and consistent wherever someone meets Weight Watchers.”
Availability
The new experience will be gradually rolling across the global market in the coming weeks, starting on Dec. 26. The Weight Watchers app is available on both iOs and Android providing a seamless and modern interface across devices.
ABOUT WEIGHT WATCHERS
Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit
weightwatchers.com
.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7fbb7fa6-5f6a-49ea-a8ec-01e8f5253182 .